Development and Validation of an RP-HPLC Method for Determination of Atorvastatin and its Hydroxyl Metabolites in Human Plasma
| Autor: | Alicja Pogorzelska, Marlena Rakicka, Marta Karazniewicz-Lada, Mateusz Malak, Justyna Sznura, Dagmara Sowinska, Justyna Janowska, Patrycja Gorzycka |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Chromatography
Chemistry Atorvastatin Biophysics Pharmaceutical Science 02 engineering and technology 030204 cardiovascular system & hematology 021001 nanoscience & nanotechnology Biochemistry 03 medical and health sciences 0302 clinical medicine Human plasma medicine Molecular Medicine 0210 nano-technology medicine.drug |
| Zdroj: | Current Pharmaceutical Analysis. 16:238-245 |
| ISSN: | 1573-4129 |
| DOI: | 10.2174/1573412914666180912110154 |
| Popis: | Background: Atorvastatin (AT) belongs to cholesterol-lowering agents, commonly used in patients with an increased risk of cardiovascular disease. The drug, as well as its hydroxyl metabolites, exhibit pharmacological activity, and their plasma levels may be helpful in the assessment of the therapeutic effectiveness. Objective: Development and validation of a fast and reproducible RP-HPLC method with UV detection for the simultaneous determination of atorvastatin and its active metabolites, para-hydroxy-atorvastatin (p-OH-AT) and ortho-hydroxy-atorvastatin (o-OH-AT) in human plasma. Methods: Optimal conditions of chromatographic separation of the analytes, as well as rosuvastatin, chosen as an internal standard, were studied. The absorbance of the compounds was measured at λ=248 nm. Validation of the method was performed. The usefulness of the method was confirmed for determination of the analytes in plasma of patients treated with the drug. Results: Total peak separation was achieved at LiChrospher 100 RP-18 column with a mobile phase composed of methanol and water (1:1,v:v) and a flow rate of 1.2 ml/min. The method was linear in the ranges of 0.025 - 1.0 μg/ml for AT, o-OH-AT and p-OH-AT. Intra- and inter-assay precision expressed as relative standard deviation was ≤13% for AT, ≤12% for p-OH-AT and ≤11% for o-OH-AT. Intraand inter-day accuracy of the method, expressed as a relative error, was ≤15%. Conclusion: The elaborated HPLC method is specific, repeatable, reproducible, adequately accurate and precise and fulfills the validation requirements for the bioanalytical method. The method was successfully applied for analysis of atorvastatin and its o-hydroxy metabolite in plasma of patients treated with the drug. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|